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A B S T R A C T
Background
Lack of adherence to blood pressure lowering medication is a major reason for poor control of hypertension worldwide. Interventions
to improve adherence to antihypertensive medication have been evaluated in randomised trials but it is unclear which interventions
are effective.
Objectives
To determine the effectiveness of interventions aiming to increase adherence to blood pressure lowering medication in adults with high
blood pressure
Search methods
All-language search of all articles (any year) in the Cochrane Controlled Trials Register (CCTR), MEDLINE, EMBASE, and CINAHL
in April 2002.
Selection criteria
RCTs of interventions to increase adherence to blood pressure lowering medication in adults with essential hypertension in primary
care, with adherence to medication and blood pressure control as outcomes
Data collection and analysis
Two authors extracted data independently and in duplicate and assessed each study according to the criteria outlined by the Cochrane
Collaboration Handbook.
Main results
We included 38 studies testing 58 different interventions and containing data on 15519 patients. The studies were conducted in nine
countries between 1975 and 2000. The duration of follow-up ranged from two to 60 months. Due to heterogeneity between studies in
terms of interventions and the methods used to measure adherence, we did not pool the results. Simplifying dosing regimens increased
adherence in seven out of nine studies, with a relative increase in adherence of 8 per cent to 19.6 per cent. Motivational strategies were
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successful in 10 out of 24 studies with generally small increases in adherence up to a maximum of 23 per cent. Complex interventions
involving more than one technique increased adherence in eight out of 18 studies, ranging from 5 per cent to a maximum of 41 per
cent. Patient education alone seemed largely unsuccessful.
Authors’ conclusions
Reducing the number of daily doses appears to be effective in increasing adherence to blood pressure lowering medication and should
be tried as a first line strategy, although there is less evidence of an effect on blood pressure reduction. Some motivational strategies and
complex interventions appear promising, but we need more evidence on their effect through carefully designed RCTs.
P L A I N L A N G U A G E S U M M A R Y
What interventions improve adherence to treatment in patients with high blood pressure in ambulatory settings
High blood pressure is a major risk factor for heart attack and stroke, and drug treatment of high blood pressure can substantially
reduce this risk. However, the control of high blood pressure in the community is far from optimal. One of the major reasons for this
is that patients with high blood pressure often fail to take their medication as prescribed. A number of interventions have been tested
that aim to help patients take their medication but it is still uncertain how effective they are.
This review evaluates the effectiveness of interventions aiming to help patients with taking blood pressure lowering medication. We
included studies in adult patients with a diagnosis of high blood pressure in a community setting and assessed interventions that aimed
to increase adherence to blood pressure lowering medication. The outcomes assessed were adherence to medication and blood pressure
changes.
For many interventions it is difficult to draw any real conclusions due to weaknesses of the included studies. However, reducing the
number of daily doses appears to be effective in increasing adherence to blood pressure lowering medication and should be tried as a
first line strategy although there is little evidence of an effect on blood pressure reduction. Some motivational strategies and complex
interventions appear promising but we need more evidence on their effect through carefully designed randomised controlled trials to
confirm these findings.
B A C K G R O U N D
Hypertension is a major risk factor in the development of car-
diovascular disease and poses a significant public health problem
(MacMahon 1990). Randomized trials have demonstrated that
treating high blood pressure with medication can substantially re-
duce the risk of stroke by 31 to 45 per cent and myocardial in-
farction by 8 to 23 per cent (Collins 1994). There is evidence that
intensification of medication by means of treatment with two or
more antihypertensive drugs is associated with improved blood
pressure control (HDFP 1986, HDFP 1984). Despite the avail-
ability of effective treatments, the control of high blood pressure
in the community is far from optimal, with lack of adherence to
blood pressure lowering medication being a major factor (Burt
1995, Colhoun 1994, Sackett 1975). Adherence in treated hyper-
tensives is estimated to be between 50 to 70 per cent (Psaty 1990,
Caro 1995), and the importance of improving adherence to long-
term therapies has recently been addressed by the World Health
Organization in a major report (Sabate 2003).
A variety of interventions aiming to improve adherence to an-
tihypertensive medication have been evaluated in randomized
controlled trials (RCTs), and five systematic reviews have tried
to summarize the evidence in this field (Dunbar-Jacob 1991;
Ebrahim 1998, Morrison 2000, McDonald 2002, Roter 1998).
The searches in three of these reviews were limited to studies in-
dexed only in MEDLINE (Dunbar-Jacob 1991, Ebrahim 1998,
Morrison 2000), thereby lacking in sensitivity and specificity
(Dickersin 1994) and only included English language publica-
tions. None of these reviews could recommend any single ap-
proaches that increase adherence to blood pressure lowering med-
ication. The most recent and more general review used a more
comprehensive literature search and included six studies in hyper-
tension (McDonald 2002).
Because more trials in this area have emerged recently (
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Blenkinsopp 2000, Andrejak 2000, Mehos 2000), this prompted
us to carry out a new systematic review of the literature to establish
which types of interventions to increase adherence are most effec-
tive, using a more comprehensive search strategy and including
publications in languages other than English. We also aimed to
investigate and report the effect of individual interventions used
in factorial trials.
O B J E C T I V E S
• To locate and describe studies evaluating interventions
aimed at improving adherence to antihypertensive medication
• To undertake a critical review of the quality of the study
methods looking in particular at study design and validity
• To summarise the effectiveness of the above interventions
• To indicate areas for future research
M E T H O D S
Criteria for considering studies for this review
Types of studies
RCTs of interventions to increase adherence to blood pressure
lowering medication.
Types of participants
Adults with a diagnostic label of essential hypertension (as defined
in individual studies) in a primary care, outpatient or other com-
munity setting.
Types of interventions
Any intervention designed to enhance medication adherence, in-
cluding the following:
1. Education of caregivers and patients (e.g. counselling, health
education)
2. Simplification of dosage regimens
3. Involvement of allied health professionals (e.g. nurses, pharma-
cists)
4. Special monitoring (e.g. vial caps, blood pressure self-measure-
ment)
5. Motivation (e.g. financial incentives, reminder packages, re-
minder aids including diaries or follow-up appointments)
Control groups should either have received no intervention or
“usual care” and have similar characteristics as the intervention
groups.
Types of outcome measures
1. Adherence tomedication (including any definition of adherence
and noting how this was defined and measured in each study)
2. Blood pressure change in mmHg or change in blood pressure
control according to the criteria used in each individual RCT. A
’net reduction’ of blood pressure refers to the ’net’ difference be-
tween the changes of blood pressure between baseline and follow-
up in the intervention and control group.
Exclusion criteria:
1. Interventions not designed to increase adherence
2. Participants suffering from secondary hypertension
3. Participants hospitalised as opposed to ambulatory
4. Study design not RCT
5. Results already reported in another publication
6. Full results not reported and further information not available
from study authors
Search methods for identification of studies
We identified original RCTs by an all-language search of all articles
(any year) in the Cochrane Controlled Trials Register (CCTR),
which now includes all RCTs that can be found in theMEDLINE
and EMBASE databases, in April 2002. We applied a systematic
search strategy using a series of topic terms to define the condition
of interest (see below). We screened the references of all retrieved
articles to identify additional publications. We contacted 25 study
authors and experts in the field about other relevant trials or un-
published material and obtained responses from 17 individuals .
Search strategy:
1 HYPERTENS*
2 BLOOD-PRESSURE*:ME
3 (BLOOD:TI near PRESSURE:TI)
4 BLOOD-PRESSURE-DETERMINATION*:ME
5 BLOOD:TI next PRESSURE:TI near MONITOR*:TI
6 #1 or #2 or#3 or #4 or #5
7 PATIENT near COMPLIANCE
8 COMPLIANCE and :TI or ADHERENCE:TI
9 PATIENT next EDUCATION
10 ADHER* or MOTIVAT*
11 AMBULATORY-CARE*:ME
12 AMBULATORY:TI
13 COUNSEL*
14 FEEDBACK
15 REMINDER-SYSTEMS*:ME
16 REMIND*
17 DRUG-INFORMATION-SERVICES*:ME
18 ATTITUDE-TO-HEALTH*:ME
19 EDUCATION* next METHODS
20 EDUCATION* next MATERIAL*
21 PUBLICATIONS*:ME
22 PAMPHLET* or BROCHURE* or LEAFLET* or POSTER*
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23 #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or
#16 or #17 or #18 or #19 or #20 or #21 or #22
24 #6 and #23
This search strategy was amended slightly for further searches of
MEDLINE, EMBASE and CINAHL.
Data collection and analysis
Study Identification
We assessed studies according to the Cochrane Handbook. Two
investigators (KS, TF) assessed lists of citations and abstracts inde-
pendently. Each reviewer indicated whether a citation was poten-
tially relevant (i.e. appearing to meet the inclusion criteria), was
clearly not relevant, or gave insufficient information to make a
judgement. We resolved differences by discussion and attempted
to obtain printed copies of all potentially relevant citations or full
paper versions of those where insufficient information was avail-
able. Both investigators assessed copies of all presumably relevant
articles independently according to the above criteria. To be in-
cluded in the review, a study had to meet all our selection criteria.
Study Selection
We independently extracted data in duplicate concerning study
design, methods, clinicians and patients, interventions, outcomes
and potential sources of bias using a structured data collection
form. As there is only a small amount of evidence available that
masking reviewers reduces the risk of bias, we were not blinded to
the source and the authors of publications.(Berlin 1997) A third
rater (SE) verified the data extraction, and corrections were made
where necessary.
Study evaluation
Due to the limited evidence on applying quality scores for individ-
ual RCTs we have presented RCT characteristics in a descriptive
format, thereby providing a more accessible and more objective
summary.(Juni 1999) Two reviewers provided data for the table
independently and in duplicate, which were verified by the third
reviewer. Disagreements were handled in the same way as for study
identification and selection. We contacted 25 corresponding au-
thors of studies to request missing data and verification of study
details.
Quantitative data analysis
Due to heterogeneity between studies in terms of interventions
and the various methods that were used to measure adherence, we
felt that pooling of the results was inappropriate. We grouped and
reported the individual arms of factorial trials separately in the
respective groups.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
We screened 1929 citations and included 38 studies that met all
our predefined criteria, involving a total of 15519 patients and
testing 58 different interventions. The table ’Characteristics of
included studies’ summarizes the characteristics of included RCTs,
whichwere conducted between1975 and2000.We chose to report
the interventions tested in factorial trials separately and treated
these like individual studies.
The majority of trials were performed in the USA (n equals 21)
and Canada (n equals 8) with the remainder located in Europe
(n equals 8), Australia (n equals 1) and South Africa (n equals
1). Study participants fell into a number of different categories
that included newly diagnosed patients, patients with established
hypertension on medication, patients with controlled or uncon-
trolled hypertension, patients adherent or non-adherent to medi-
cation or infrequent attendees at clinic.
In view of a lack of a generally accepted categorization, we grouped
studies arbitrarily into the following four pragmatic categories: (i)
simplification of dosing regimens, (ii) patient education, (iii) pa-
tient motivation, support and reminders and (iv) complex health
and organizational interventions including interventions in com-
bination.
Adherence was measured in different ways, including self-report,
direct questioning, pill counts, and the medication event moni-
toring system (MEMS®), which logs the time and date of each
opening of a medication container. Various criteria for adherence
were used in the different studies. All studies examined both men
and women in varying proportions, and the duration of follow-
up ranged from two to 60 months.
Risk of bias in included studies
The methodological quality of included studies was generally low
(see Table 1). The randomization process was reported and pro-
vided adequate concealment of allocation in only 10 out of the
38 studies (26 per cent). The outcome assessors were blind to
treatment allocation in 12 studies (31 per cent). Losses to follow-
up were well documented in 33 studies (85 per cent). Only eight
trials (21 per cent) reported a power calculation, and most of the
remaining trials appeared too small to detect clinically important
differences. None of the included studies fulfilled all the quality
criteria.
Effects of interventions
EFFECT ON ADHERENCE AND BLOOD PRESSURE
Individual RCTs reported results on adherence in many different
ways, making a pooled analysis inappropriate. Nineteen studies
reported an improvement in adherence alone, of which 13 also
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reported blood pressure changes. Seven RCTs found an improve-
ment in adherence combined with a reduction in blood pressure,
and in seven studies a reduction in blood pressure occurred with-
out an increase in adherence. Fifteen of the included studies (26
per cent) did not report a blood pressure outcome, and none of
the studies examined major clinical endpoints.
Please note that in the following section, the total number of RCTs
(i.e. interventions) is 58 rather than 38. This is because some
studies reported the results of factorial trials testing two or more
different interventions, which we have evaluated separately.
(i) SIMPLIFICATION OF DOSING REGIMENS (nine study
interventions)
Interventions evaluated in this category included once daily versus
twice daily preparations of metoprolol, amlodipine, or enalapril.
One study tested transdermal clonidine plus placebo tablets versus
verapamil and a transdermal placebo (Burris 1991). Asplund and
colleagues compared pindolol and clopamide combined in one
tablet versus both drugs in separate tablets.
Simplifying dosing regimens improved adherence in seven out of
nine studies (Andrejak 2000, Baird 1984, Boissell 1996, Detry
1995, Leenen 1997,Mounier-Veh. 1998, Girvin 1999), with rela-
tive improvement in adherence ranging from8 to 19.6 per cent. All
five studies in this category that used objective outcome measure-
ment (MEMS®) showed an improvement in adherence through
the use of once-daily instead of twice-daily dosage regimens, al-
though four of these compared two different drugs. Seven studies
also reported blood pressure changes. Only one study showed an
increase in adherence (90 versus 82 per cent, p less than 0.01)
together with a reduction in systolic blood pressure of 6 mmHg
systolic (p less than 0.01) (Leenen 1997). However, the changes
in diastolic blood pressure in this study were insignificant.
(ii) PATIENT EDUCATION (six study interventions)
Educational interventions in the included studies consisted of
an educational programme via slides, audiotape and booklet
(Sackett 1975), group education (Webb 1980; Pierce 1984;
Marquez-Contr. 1998), written educational material (Kirscht
1977), and education via visual aids, lecture, discussion andknowl-
edge test (Kerr 1985).
Patient education seemed largely unsuccessful. Only a single and
relatively small trial (n=110) improved adherence (93 versus 69
per cent, p less than 0.002) with no reported effect on blood
pressure (Marquez-Contr. 1998). This study used group education
in groups of 15 people over 90 minutes and additional postal
information leaflets at one, three and five months.
(iii) PATIENT MOTIVATION, SUPPORT AND RE-
MINDERS (24 study interventions)
In this category, we included interventions such as special com-
pliance dispensers (Becker 1986; Eshelman 1976; Rehder 1980;
McKenney 1992; Skaer 1993), drug reminder charts (Gabriel
1977), self-recording of blood pressure (Johnson 1978; Kirscht
1977; Kerr 1985; Zarnke 1997), monthly home visits (Johnson
1978), teaching on self-determination (Nessman 1980), counsel-
ing (Rehder 1980; Webb 1980; Morisky 1985; Park 1996), nurse
phone calls (Kirscht 1977), social support (Kirscht 1977; Morisky
1985), small group training (Morisky 1985), postal reminders
(Skaer 1993), and telephone-linked computer counselling (an in-
teractive computer based telecommunications system that con-
verses with patients in their homes between office visits to their
physicians) (Friedman 1996).
Motivational strategies were successful in 10 out of 24 study in-
terventions with mostly small increases in adherence up to a maxi-
mum of 23 per cent (Kirscht 1977, Gabriel 1977, Nessman 1980,
Friedman 1996, McKenney 1992, Morisky 1985, Skaer 1993,
Kirscht 1977). All of these studies used methods of measuring
adherence, such as pill counts, self-report, direct questioning, and
prescription refill records, which are less reliable than electronic
monitoring (Urquhart 1997). Successful interventions included
daily drug reminder charts (mean adherence score 82.4 versus 70.4
per cent, p=0.002) (Gabriel 1977), training on self-determination
(4.6 out of 7 weeks adherent versus 3.3 weeks in the control group,
p less than 0.001) (Nessman 1980), reminders and packaging (in-
crease in adherence between 8 per cent for reminders alone and 23
per cent for reminders and packaging in combination, p less than
0.05) (Skaer 1993), social support (98 per cent achieved maxi-
mum adherence score versus 93 per cent, p less than 0.05) (Kirscht
1977), nurse phone calls (96 per cent achieved maximum adher-
ence score versus 91 per cent, p less than 0.05) (Kirscht 1977),
family member support (53 per cent high adherers versus 40 per
cent low adherers, p less than 0.05) (Morisky 1985), electronic
medication aid cap (mean adherence 95 per cent versus 78 per
cent, p=0.0002) (McKenney 1992), and telephone-linked com-
puter counseling (18 per cent adherent versus 12 per cent in the
control group, p=0.03) (Friedman 1996).
(iv) COMPLEX HEALTH AND ORGANI-
ZATIONAL INTERVENTIONS INCLUDING INTERVEN-
TIONS IN COMBINATION (19 study interventions)
The interventions in this category consisted mainly of complex
combined interventions or structured hypertension management
(see table of included studies for further details).
Complex interventions increased adherence in eight out of 18
study interventions (Blenkinsopp 2000, Burrelle 1986, Logan
1979, Sclar 1991, Solomon 1998, Haynes 1976, Saunders 1991),
ranging from five per cent to a maximum of 41 per cent. Worksite
care through specially trained nurses improved adherence (67 per
cent versus 49per cent, p less than0.005) and led to a net reduction
in diastolic blood pressure of 4 mmHg between intervention and
control groups (p less than 0.001) (Logan 1979). A combination
of home visits, education and special dosing devices improved
adherence in a small trial of 16 patients (92 per cent versus 71 per
cent, p less than 0.001) (Burrelle 1986). A strategy involving an
educational leaflet, a telephone reminder, a mailed reminder and
an educational newsletter was successful in both previously treated
hypertensives (’medication possession ratio’ 82 per cent versus 48
per cent, p less than 0.05) and those who were newly diagnosed
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(93 per cent versus 52 per cent, p less than 0.05) (Sclar 1991). Two
fairly recent trials reported weak evidence of an effect of a patient-
centered pharmaceutical care model in which pharmacists either
used a structured, brief questioning protocol to identify patients’
medication related problems and their information needs relating
to hypertension and its treatment (compliance score 0.23 versus
0.61, p less than 0.05) (Solomon 1998), or a combination of
structured brief questioningprotocol with advice, information and
referral to the family practitioner (62 per cent adherent versus 50
per cent, p less than 0.05) (Blenkinsopp 2000). In this study, blood
pressure was also better controlled (i.e. blood pressure readings of
159/89 mmHg or below) in the intervention group (35.7 per cent
became controlled versus 17.1 per cent, p less than 0.05), although
blood pressure data were available only for a subset of participants.
D I S C U S S I O N
Summary of key findings
In this systematic review we found RCTs that evaluated a num-
ber of strategies to improve adherence to blood pressure lowering
medication, including simplification of dosing regimens, patient
education, motivation, support, and reminders as well as complex
health and organizational interventions including interventions in
combination. Simplification of dosing regimens increased adher-
ence in seven out of nine studies, with improvement in adherence
ranging from 8 to 19.6 per cent. Adherence in these studies was
mainly measured with electronic monitors and these results con-
firm findings from past research. There was inconclusive evidence
for the effect of motivational and more complex interventions.
Education alone appeared largely unsuccessful. An effect on both
adherence and blood pressure was only observed in seven out of
58 interventions (18 per cent). While an effect on both adherence
and blood pressure was only observed for a minority of interven-
tions, not all studies reported blood pressure outcomes.
INTERPRETATION OFTHE RESULTS IN THE LIGHTOF
PREVIOUS RESEARCH
This review differs from previously published reviews in that we
used a more comprehensive search strategy and different method-
ology. Compared to the latest reviews on adherence enhancing
strategies (Morrison 2000; McDonald 2002), we found and in-
cluded considerably more studies (nine and 32 more studies re-
spectively). The review by Morrison extracted categorical data in
preference to continuous data and ignored evidence from trials
where data could not be converted. This may have been partic-
ularly relevant for the results in the group with changes in med-
ication dosing, where we come to the opposite conclusion. This
review is also different in that we have reported the results from
individual arms of factorial trials separately.
We agree with the review by McDonald et al that for complex in-
terventions it is often difficult to estimate the independent effects
of individual interventions (McDonald 2002). It also remains dif-
ficult to disentangle specific adherence effects as opposed to non-
specific effects of increased attention. Our findings confirm that
even themost effective interventions do not appear to lead to large
improvements in adherence and blood pressure reductions. How-
ever, clinical outcomes were not measured and BP measurements
were not included in all of the studies.
An earlier review of research on adherence reported benefits of
educational interventions in improving adherence (Dunbar-Jacob
1991). However, we were unable to confirm this finding, perhaps
because our review was limited to evidence from randomised trials
only.
LIMITATIONS OF THIS REVIEW
Comparing the RCTs included in this review was difficult. Many
RCTs showedmarkedheterogeneity in terms of participants, inter-
ventions and outcomes. Study authors also measured and reported
adherence inconsistently. Individual RCTs demonstrated variable
and often poor methodological quality, particularly with regard
to randomization, blinding of outcome assessment and losses to
follow-up, whilst the sample sizes of many trials were too small to
detect clinically relevant differences. Rather surprisingly, 15 out
of the included 38 studies (39%) did not report a blood pressure
outcome, and none reported major clinical endpoints.
There are also some difficulties in interpreting the results of this
systematic review. Adherence was measured (e.g. self-report, pill
counts, direct questioning, electronic monitoring, drug blood lev-
els) and calculated in different ways (e.g. using arbitrary cut-off
points to define adherence such as 80%), and in addition was
usually assessed unblinded to allocation status, which made the
comparison of RCTs difficult. Levels of adherence in the control
groups of the trials studied ranged from 12% to 94%, which is
indicative of the heterogeneity in both criteria for defining adher-
ence and the participants studied. With no agreed definitions on
how adherence should be measured and defined, it is not surpris-
ing that for most interventions the impact on adherence and blood
pressure appears to be variable. Because of the different definitions
for adherence that have been adopted in individual RCTs, it has
not been possible to examine the relationship between adherence
to medication and subsequent blood pressure control. Our cate-
gorization and grouping of trials was arbitrary, and the group al-
location of some trials might be debatable.
It is possible that the interventions tested in the factorial trials
were not independent from each other. Particularly in the case of
complex interventions evaluated in factorial trial designs, inter-
actions are likely, and the results have therefore to be interpreted
with caution.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Our findings suggest that introducing simpler dosing regimens can
be effective in improving adherence, but the effect on subsequent
blood pressure reduction has not been established and may not be
clinically important. The results of various motivational and more
complex interventions are promising, although there is insufficient
evidence to suggest a single approach.
We suggest that innovative approaches should be introduced in
the context of further RCTs. It is important that physicians are
aware of the various reasons for poor adherence and aim to simplify
dosing regimes as far as possible.
Different health professionals were involved in delivering the in-
terventions in the studies included in this review. In many coun-
tries, the role of allied health professionals such as nurses or physi-
cian assistants is expanding, which may lead to new management
opportunities for tackling adherence-related problems in patients
with high blood pressure.
Implications for research
The results of this review highlight a number of problem areas in
adherence related research. Many studies used unreliable meth-
ods of measuring adherence such as self-report and pill counts. It
appears that electronic monitoring provides more objective and
reliable results and, in addition, produces data on medication tak-
ing patterns (Urquhart 1997). Although a large number of studies
have been conducted in this area, larger trials of higher quality
are needed that use reliable methods of measuring adherence and
that also investigate the relationship between adherence and blood
pressure reduction. We feel this is particularly important in the
context of an increasing elderly population of people who often
take multiple medications.
Hypertensive patients may fail to take their medication due to the
long duration of therapy, the symptomless nature of the condi-
tion, side effects of medication, complicated drug regimens, lack
of understanding about hypertension management, lack of mo-
tivation and the challenge to individual patients’ health beliefs
(Ebrahim 1998; Dowell 2002). It would seem logical that future
studies should try and adopt a ’tailored’ approach aimed at in-
dividual patients and addressing the above mentioned barriers to
adherence (Working Party 1997). Combinations of strategies that
include simpler dosage regimens, patient motivation and that in-
volve other health professionals in a patient-centered approach
should be further investigated. In addition, patients’ views should
be taken into account when piloting interventions, and the inter-
ventions themselves should be based on shared decision-making
in a partnership between patient and practitioner (Bowling 2001;
Sieber 2000; Thomson 2001; Rand 2000).
It is paramount that every study that evaluates an intervention to
increase adherence to blood pressure lowering medication should
also measure blood pressure as a second outcome to help examine
the relationship between adherence and blood pressure control.
Finally, only one RCT underwent an economic evaluation, which
showed that nurse-led work-site care was not cost-effective, with
an incremental cost-effectiveness ratio almost double that of usual
care (Logan 1983). It is important that future studies include eco-
nomic analyses because adherence interventionswill generally have
cost implications. Adherence to blood pressure lowering medica-
tion must persist long-term to show a clinically relevant benefit.
Many studies included in this review had a follow-up period of
less than six months (see table of Characteristics of Studies). We
therefore suggest that interventions in future studies should be
tested over a period of at least six months.
We conclude that simplification of dosing regimens appears to be
the most promising intervention to increase adherence to blood
pressure lowering medication. The results of this review should be
interpreted with caution due to the poor methodological quality
and heterogeneity of trials included in this review. Our findings
emphasize the need for further RCTs with sufficient power and of
rigorous methodology.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Andrejak 2000
Methods Parallel trial, study duration six months, follow -up at six months
Participants 162 participants with mild to moderate hypertension, 45 per cent men, mean age 57 years, multi-centre, France
Interventions SIMPLIFICATION OF DOSING REGIMENS: once daily trandolapril 2mg versus twice daily captopril 25mg
Outcomes ELECTRONIC MONITORING: percentage of correct dosing 94 per cent in intervention group compared to 78.
1 per cent among controls, p less than 0.0001
Notes Study compared two different drugs.
Asplund 1984
Methods Cross-over trial, intervention four months on each regimen, follow-up at eight months
Participants 160 participants with treated and controlled hypertension, 61 per cent men, mean age 51 years, hospital outpatients
in Sweden
Interventions SIMPLIFICATIONOFDOSINGREGIMENS: pindolol 10mg and clopamide 5mg once daily in one combination
tablet versus two tablets
Outcomes PILL COUNT AND SELF REPORT: 40.8 per cent never forgot a tablet in the experimental group versus 69 per
cent in the control group (not statistically significant, but no exact p-value reported)
Net increases of 2.8 mmHg systolic and 3.0 mm Hg diastolic (not statistically significant, no exact p-value reported)
Notes Dropouts not clearly reported
Baird 1984
Methods Parallel, study duration eight weeks, follow-up at 10 weeks
Participants 389 participants with treated and controlled hypertension, 70 per cent men, mean age 54 years, primary care, Canada
Interventions SIMPLIFICATION OF DOSING REGMENS: Metoprolol 200mg once daily versus metroprolol 100mg twice
daily
Outcomes PILL COUNT: 96 per cent took more than 80 per cent of medication in the intervention group (once-daily regimen)
compared to 90 per cent in the control group (p equals 0.059). 93 per cent took more than 90 per cent of medication
in the intervention group compared to 82 per cent in the control group (p equals 0.009). 1 mmHg net reduction
in systolic blood pressure and no net reduction for diastolic blood pressure (not statistically significant, no exact p-
value reported)
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Baird 1984 (Continued)
Notes Detailed reasons for loss to follow-up reported. Randomisation procedure and blinding to outcome assessment unclear
Becker 1986
Methods Parallel, study duration one year, follow-up at one year
Participants 180 participants with treated and uncontrolled hypertension, primarily middle aged black women, less than 20 per
cent employed, primary care in USA
Interventions PATIENT MOTIVATION, SUPPORT AND REMINDERS: special unit dose reminder packaging versus usual
medication vials
Outcomes PILL COUNT AND SELF REPORT: 84 per cent adherent in the intervention group compared to 75 per cent
among the controls (not statistically significant, no exact p-value reported). Net reduction in diastolic blood pressure
0.2 mmHg (not statistically significant)
Notes Physicians blinded to treatment allocation, aware that compliance study was in progress but unaware of the aims of
the study
Blenkinsopp 2000
Methods Cluster-randomised parallel, study duration six months
Participants 180 participants with treated hypertension, 62 per cent age 60 or over, 20 community pharmacy sites, UK
Interventions COMPLEX HEALTH AND ORGANISATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: structured brief questioning protocol on medication problems, including advice, information and referral to
general practitioner by pharmacists three times at two-month intervals
Outcomes SELF REPORT: 62 per cent adherent in the intervention group compared to 50 per cent in the control group (p
less than 0.05). 35.7 per cent of uncontrolled patients became controlled in the intervention group compared to 17.
1 per cent in the control group (p less than 0.05)
Notes Complete data on blood pressure only available on 100 participants, high likelihood of bias
Boissell 1996
Methods Parallel, study duration three months, follow up at three months
Participants 7272 participants, 50 per cent men, mean age 61 years, primary care, France
Interventions SIMPLIFICATION OF DOSING REGIMENS: nicardipine 20 mg thrice daily versus nicardipine SR 50 mg twice
daily
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Boissell 1996 (Continued)
Outcomes SELF REPORT: 82 per cent of participants in intervention group reported excellent adherence compared to 76
per cent among controls (p less than 0.001). Net reduction in blood pressure 0.2 mmHg (systolic) and 0.3 mmHg
(diastolic). Not statistically significant, no exact p-value reported
Notes No differential loss to follow-up reported, high participant number due to large number of participating general
practitioners, bias likely
Burrelle 1986
Methods Parallel, study duration eight weeks, follow-up at eight weeks
Participants 16 participants with treated hypertension and non-adherent, 75 per cent black, 75 per cent female, mean age 69
years, hospital outpatients and primary care, USA
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: Home visits, education, special dosing devices versus usual care
Outcomes PILL COUNT AND SELF REPORT: Percent of pills taken: 92 per cent in the intervention group compared to
71 per cent in the control group (p less than 0.0001). Net reduction in blood pressure 7 mmHg (systolic) and net
increase of 7 mmHg in diastolic blood pressure (p greater than 0.05)
Notes Small study, likelihood of bias.
Burris 1991
Methods Parallel, study duration eight weeks, follow up at eight weeks
Participants 58 participants with treated and uncontrolled hypertension, mean age 67/68 years (intervention/control), 76/66 per
cent male (intervention/control), hospital outpatients, USA
Interventions SIMPLIFICATION OF DOSING REGIMENS: transdermal clonidine 0.1mg per day with placebo tablets versus
verapamil SR 120mg daily plus transdermal placebo
Outcomes PILL COUNT, VISUAL ASSESSMENT: 96 to 100 per cent of participants wore the active patch at every visit
compared to 100 per cent using the placebo patch. 68 to 88 per cent had optimal tablet counts in the verapamil SR
group compared to 11 to 37 per cent in the control group (p-values not reported). Net reduction 5 mmHg (systolic)
and 1 mmHg (diastolic), p less than 0.05
Notes No probability values reported for adherence outcome. Study compared different drugs. Different methods used to
assess adherence in both groups. High likelihood of bias
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Detry 1995
Methods Crossover, study duration 12 weeks, follow-up at 12 weeks
Participants 320 participants with uncontrolled hypertension, age under 70 years, mean age 60 years, 52 per cent male, hospital
outpatients, Belgium
Interventions SIMPLIFICATION OF DOSING REGIMENS: amlodipine 5mg daily versus nifedipine 20mg twice daily
Outcomes PILL COUNTS AND ELECTRONIC MONITORING: therapeutic coverage 93.7 per cent in the intervention
group versus 75.9 per cent in the control group (p less than 0.001). Blood pressure changes not reported
Notes Crossover RCT, patients double-counted. Randomisation procedure not reported. Study compared two different
drugs
Eshelman 1976
Methods Parallel, study length and timing of follow-up not reported
Participants 100 participants with treated hypertension, no baseline data reported, hospital outpatients and pharmacy department,
USA
Interventions PATIENTMOTIVATION, SUPPORT AND REMINDERS: compliance dispenser versus usual medication bottle
Outcomes PILL COUNT AND SELF REPORT: 63 per cent adherent in the intervention group compared to 61 per cent in
the control group (not statistically significant, no exact p-value reported)
Notes Dropouts at least 33 per cent with no differential loss to follow-up reported. Bias likely
Friedman 1996
Methods Parallel, study duration six months, follow-up at six months
Participants 267 participants with treated hypertension, 90 per cent white, 77 per cent women, mean age 76 years, primary care,
USA
Interventions PATIENT MOTIVATION, SUPPORT AND REMINDERS: telephone linked computer counselling versus usual
care
Outcomes PILL COUNT: 18 per cent adherent in the intervention group compared to 12 per cent in the control group (p
equals 0.03). Net reduction in blood pressure 4.7 mmHg systolic (p equals 0.85) and 4.4 mmHg diastolic (p equals
0.09)
Notes Treatment provider blinded until baseline measurement completed. Randomisation by ’paired randomisation pro-
tocol’
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Gabriel 1977
Methods Parallel, 3 1/2 months follow-up
Participants 79 participants with treated hypertension, mean age 65 years, mainly black women, pharmacy at community health
center, US
Interventions PATIENTMOTIVATION, SUPPORTANDREMINDERS: daily drug reminder chartwith pharmacist supervision
Outcomes PILL COUNT AND SELF REPORT: mean compliance score 82.4 per cent in the intervention group compared to
70.4 per cent in the control group (p equals 0.002)
Notes Small study, no power calculation reported, unreliable assessment of adherence
Girvin 1999
Methods Cross over, three months follow -up
Participants 27 participants with controlled hypertension, 64 per cent men, mean age 62 years, general practices, Northern Ireland
Interventions SIMPLIFICATION OF DOSING REGIMENS: enalapril 20mg once daily versus Enalapril 10mg twice daily
Outcomes ELECTRONIC MONITORING: 92.2 per cent adherent in intervention group versus 72.6 per cent in the control
group (p less than 0.001). 5.3 mmHg net reduction in systolic and 1.0 mmHg net reduction in diastolic blood
pressure (p equals 0.068 and 0.086 respectively)
Notes Patient selection with potential for selection bias.
Hamilton 1993
Methods Parallel, six months follow up
Participants 34 participants with treated hypertension, mean age 54 years, white, married, high school educated, hypertension
clinic in tertiary care teaching medical center, US
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: postcard reminder, nurse-led educational appointment and follow-up phone call compared with usual care
Outcomes SELF REPORT: adherence score of 27.5 in intervention group compared to 24.5 in control group (p equals 0.12).
Net reductions of blood pressure 17.3 mmHg systolic and 4.7 mmHg diastolic (p equals 0.03 and 0.22 respectively)
Notes Small study.
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Hawkins 1979
Methods Parallel study, 29 months follow -up
Participants 1148 participants with hypertension and diabetes, hospital outpatient clinic, mean age 60 years, 76 per cent women,
USA
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: post-diagnostic management of patients with hypertension and diabetes by clinical pharmacist versus usual
physician review
Outcomes PRESCRIPTION RECORD: diuretic only: 60.5 per cent adherent in intervention group versus 52.9 per cent in the
control group (p less than 0.7), diuretic plus methyldopa: 84.6 per cent adherent in intervention group versus 65.4
per cent among controls (p equals 0.2). Net reduction in blood pressure 4 mmHg systolic and 0 mmHg diastolic (p
less than 0.001 and not significant with no exact p-value reported, respectively, for both groups combined)
Notes High losses to follow-up (45 per cent)
Haynes 1976
Methods Parallel, study duration one year, follow-up at one year
Participants 39 participants with treated and uncontrolled hypertension, male steel workers, work-site, Canada
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: Self-measurement of blood pressure, medication and blood pressure charting, tailoring to daily routines,
fortnightly review and rewards (financial and praise) versus no intervention
Outcomes PILL COUNT: 66 per cent adherent in the intervention group compared to 43 per cent among the controls (p less
than 0.025). Net reduction in diastolic blood pressure 4 mmHg (p=0.12)
Notes Small study. Potential sources of bias well reported. Study was underpowered to detect an effect on blood pressure
Johnson 1978
Methods Factorial, study duration six months, follow-up at six months
Participants 204 participants with treated but uncontrolled hypertension, 60 per cent women, mean age 54/52 years (men/
women), primary care, Canada
Interventions COMPLEX HEALTH AND ORGANISATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: self-recording of blood pressure and monthly home visits, self-recording only, monthly home visits only
versus no intervention
Outcomes Increase in adherence 10 per cent (self-monitoring plus visits), 12 per cent (self-monitoring only) and ten per cent
(home visits only) compared to one per cent decrease in the control group (not significant, no exact p-value reported)
. Reductions in diastolic blood pressure 1mmHg (self-monitoring plus home visits), 2 mmHg (self-monitoring only)
and 2 mmHg (home visits only), all not statistically significant, but no exact p-value reported
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Johnson 1978 (Continued)
Notes Power calculation not reported but probability of type II error quantified in the discussion
Kerr 1985
Methods Parallel, study duration one day, follow up at three months
Participants 235 employees, 57 per cent men, mean age 50.3 years, work-site, USA
Interventions COMPLEX HEALTH AND ORGANISATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: Education and self-monitoring, self-monitoring only, education only versus no intervention
Outcomes SELF REPORT: Per cent of pills taken: 100 per cent (education and self-monitoring), 84 per cent (self-monitoring
only) and 81 per cent (education only) versus 100 per cent (control), not statistically significant. Reduction in diastolic
blood pressure zero mmHg (education and monitoring) and increases in diastolic blood pressure of 1 mmHg (self-
monitoring only) and 5 mmHg (education only), not statistically significant
Notes Large dropouts in all groups, inconsistencies between denominators in tables and dropouts that vary for blood pressure
and adherence outcomes
Kirscht 1977
Methods Parallel, study duration one day, follow-up at three months
Participants 400 participants with treated hypertension, nearly all white, 78 per cent age over 50, primary care, USA
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: Four sequential interventions four months apart: Education, nurse phone calls, self-recording of blood pres-
sure, social support versus usual care
Outcomes SELFREPORT:Percentage ofmaximumadherence score achieved (intervention versus control): Educationalmaterial
91 versus 90 per cent (not significant), nurse phone calls 96 versus 91 per cent (not significant), self-monitoring 94
versus 94 per cent (not significant) and social support 98 versus 93 per cent (p less or equal to 0.05). Blood pressure
changes not reported
Notes Results difficult to interpret due to unclear reporting of adherence scores
Leenen 1997
Methods Parallel, study duration 20 weeks, follow-up at 20 weeks
Participants 198 participants with newly diagnosed hypertension, 60 per cent men, mean age 55 years, primary care, Canada
Interventions SIMPLIFICATION OF DOSING REGIMENS: Amlodipine 5mg daily versus diltiazem SR 60mg twice daily
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Leenen 1997 (Continued)
Outcomes ELECTRONIC MONITORING (MEDICATION EVENTMONITORING SYSTEM): 90 per cent adherent in
intervention group compared to 82 per cent in the control group (p less than 0.01). Net reduction in systolic blood
pressure 6 mmHg (p less than 0.01) and diastolic blood pressure 1 mmHg (not statistically significant, no exact p-
value reported)
Notes Study compared two different drugs. Bias likely.
Logan 1979
Methods Parallel, study duration six months, follow up at six months
Participants 457 volunteers from business, newly diagnosed hypertension, 88 per cent white, 79 per cent male, mean age 47 years,
work-site, Canada
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: Nurse-led work-site care versus usual care
Outcomes PILL COUNT: 67 per cent adherent in the intervention group compared to 49 per cent in the control group (p less
than 0.005). Reduction in blood pressure 4 mmHg diastolic (p less than 0.001)
Notes Differential loss to follow-up well reported
Logan 1983
Methods Parallel, study duration one year, follow-up at one year
Participants 194 participants, uncontrolled hypertensive business employees, 84 per cent white, 73 per cent male, business
employees, work site, Canada
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: nurse-led care versus usual care
Outcomes PILL COUNT: 55 per cent adherent in the intervention group compared to 56 per cent in the control group (not
statistically significant, no exact p-value reported). Net reduction in diastolic blood pressure 3mmHg (not significant)
Notes Randomisation process unclear
Marquez-Contr. 1998
Methods Parallel, study duration six months, follow-up at six months
Participants 110 participants with newly diagnosed and established treated hypertension, 71 per cent women, mean age 59 years,
primary care, Spain
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Marquez-Contr. 1998 (Continued)
Interventions PATIENT EDUCATION AND COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, IN-
TERVENTIONS IN COMBINATION: group sessions with information about blood pressure management and
postal education (with information on blood pressure and the importance of compliance, sent at months one, three
and five) versus usual care
Outcomes PILL COUNT: 93 per cent adherent in the intervention group compared to 69 per cent in the usual care group (p
less than 0.002). Reduction in blood pressure not reported
Notes Differential loss to follow-up in both treatment arms not reported
McKenney 1992
Methods Two-phase parallel, study duration two times 12 weeks, follow-up at 12 and 24 weeks
Participants 70 participants, 70 per cent white, 59 per cent women, mean age 73 years
Interventions PATIENT MOTIVATION, SUPPORT AND REMINDERS: electronic medication aid cap with recording card
and blood pressure cuff versus usual drug bottle
Outcomes PILL COUNT:
PHASE I:
Mean adherence 95 per cent in the intervention group compared to 78 per cent among controls (p equals 0.0002)
. Net reduction in blood pressure intervention versus control 4.8 mmHg systolic (p equals 0.0006) and 8.6 mmHg
diastolic (p less than 0.001)
PHASE II:
Mean adherence rates 93.6 per cent for cap only (p equals 0.003), 98.7 per cent for cap and card (p less than 0.001)
, 100.2 per cent for cap card and cuff (p less than 0.001) versus 79 per cent in the control group. Net blood pressure
reduction 12.3 mmHg systolic (p less than 0.01) and 19.2 mmHg diastolic (p equals 0.0001) for cap and card. Net
blood pressure reduction 19.5mmHg systolic (p equals 0.0006) and 12.7 mmHg diastolic (p=0.0006) for cap, card
and cuff
Notes Nine patients required change of medication during second phase, and their blood pressure measurements were not
included in the analysis
Mehos 2000
Methods Parallel, six months follow-up
Participants 41 participants with uncontrolled hypertension, mean age 59 years, 70 per cent women, single family medicine clinic,
US
Interventions COMPLEX HEALTH AND ORGANISATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: home blood pressure measurement, diary, instruction to measure blood pressure, information on hyperten-
sion and risk factor with subsequent evaluation by clinical pharmacist versus usual care
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Mehos 2000 (Continued)
Outcomes PRESCRIPTION REFILL DATA: mean adherence 82 per cent in intervention group versus 89 per cent in the
control group (p equals 0.29). Blood pressure net reduction 10.1 mmHg systolic (p equals 0.069) and 6.7 mmHg
diastolic (p equals 0.02)
Notes Patients randomised using a ’deck of cards’
Morisky 1985
Methods Sequential factorial, study duration three years, follow-up at five years
Participants 193 participants with treated hypertension, 91 per cent black, 70 per cent women, median age 54 years, USA
Interventions PATIENT EDUCATION: re-inforcement interview, family member support, small groups versus usual care
Outcomes SELF REPORT: high adherers: 53 per cent (family support), 36 per cent (counselling) and 40 per cent (small group
training) versus 40 per cent in the usual care group (p less than 0.05, not significant and not significant respectively)
. Control of blood pressure (control being defined as equal or less than 140/90 mmHg in patients age 39 and under;
equal or less than 150/95 mmHg for ages 40 to 59; equal or less than 160/100 age 60 or older) 75 per cent (family
support), 54 per cent (counselling) and 46 per cent (small group training) in the intervention groups compared to
50 per cent in the control group (p less than 0.05, not significant and not significant, respectively)
Notes No significant differences between dropouts and those who continued to receive care
Mounier-Veh. 1998
Methods Parallel, study duration 12 weeks, follow-up at 12 weeks
Participants 103 participants with treated and uncontrolled hypertension, mean age 54 years, 27 per cent women, primary care,
France
Interventions SIMPLIFICATION OF DOSING REGIMENS: amlodipine 5mg once daily versus nifedipine 20mg twice daily
Outcomes ELECTRONIC MONITORING: 92.5 per cent adherent in the intervention group compared to 74.8 per cent
among the controls (p less than 0.001). net reduction in systolic blood pressure 0.8 mmHg and 1.1 mmHg net
increase in diastolic blood pressure (not statistically significant, no exact p-value reported)
Notes Treatment allocation according to ’enrollment order’ and ’randomisation list’, study compares two different drugs
Nessman 1980
Methods Parallel, study duration eight weeks, follow-up at six months
Participants 52 non-adherent participants with treated but uncontrolled hypertension, 75 per cent white, 98 per cent male, mean
age 55 years, hospital outpatients, USA
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Nessman 1980 (Continued)
Interventions PATIENT MOTIVATION, SUPPORT AND REMINDERS: nurse and psychologist teaching self-determination
versus nurse and protocol-run clinic (control)
Outcomes PILL COUNT: intervention group compliant for 4.6 out of seven weeks versus 3.3 weeks in the control group (p
less than 0.001). Reduction in systolic blood pressure 6 mmHg (p less than 0.05)
Notes Only 10 per cent of eligible patients took part in the study which may have led to self-selection
Park 1996
Methods Parallel, four months follow-up
Participants 64participants,mainlywhitewith treated hypertension, 50 per centwomen,mean age 60 years, two chain pharmacies,
US
Interventions PATIENT MOTIVATION, SUPPORT AND REMINDERS: pharmacy-based education and counselling
Outcomes PILL COUNT: mean adherence 86.6 per cent in the intervention group compared to 89.1 per cent in the control
group (not statistically significant, no exact p-value reported)
Notes Small sample size, method of randomisation unclear.
Pierce 1984
Methods Factorial trial, six months follow-up
Participants 115 participants with uncontrolled hypertension, mean age 57 years, 60 per cent women, one general practice clinic,
Western Australia
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: Self monitoring of blood pressure and health education alone and in combination versus usual care
Outcomes PILL COUNT AND SELF REPORT: self-monitoring and education: 26 per cent good adherers versus 24 per cent
in the control group (not significant, no exact p-value reported), self-monitoring only: 30 per cent versus 24 per cent
(not significant, no exact p-value reported), education only: 28 per cent versus 24 per cent (not significant, no exact
p-value reported). BLOOD PRESSURE: education: 83 per cent had blood pressure reduction versus 67 per cent
among controls (p less than 0.05, effect size unclear), self monitoring: 74 per cent versus 78 per cent (not significant,
no exact p-value reported, effect size unclear), both education and self monitoring combined: 74 per cent versus 78
per cent, no exact p-value reported, effect size unclear)
Notes Randomisation procedure prone to bias. Reporting of outcomes inadequate
22Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rehder 1980
Methods Factorial, study duration three months, follow-up at six months
Participants 150 participants with treated hypertension, 92 per cent black, 75 per cent women, mean age 50 years, hospital
outpatients, USA
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: Counselling with special medication container and special medication container only versus usual medication
vials
Outcomes PILL COUNT: 99 per cent (counselling and container), 94 per cent (container only) and 90 per cent (counselling
only) versus 88 per cent among the controls, not statistically significant (no exact p-value reported)
Notes High dropout rate and small sample size for a factorial trial
Sackett 1975
Methods Factorial, study duration not reported, follow-up at six months
Participants 230 male steel workers, work site, Canada
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: doctor-led work site care, educational programme, both interventions versus neither intervention (control)
Outcomes PILL COUNT: 54 per cent of those receiving augmented convenience adherent compared to 51 per cent receiving
usual care (not statistically significant) 50 per cent adherent in education group compared to 56 per cent among
controls (not statistically significant). Net increase of the percentage of participants with controlled blood pressure
(diastolic blood pressure less than 90mmHg) of 4 per cent for physician-led work site care and five per cent (physician-
led work site care plus education), not statistically significant
Notes No power calculation as such, but important effect size reported a priori
Saunders 1991
Methods Parallel, study duration six months, follow-up at six months
Participants 224 participants, newly diagnosed or infrequently attending, black, 73 per cent women, about 65 per cent aged 40
to 59 years in two intervention groups, Soweto, South Africa
Interventions COMPLEX HEALTH AND EDUCATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINATION:
written reminders, patient-held records, home visits versus usual care
Outcomes PILL COUNT: 31 per cent (newly diagnosed) and 68 per cent (infrequent attenders) adherent in the intervention
group versus 15 per cent (newly diagnosed) and 37 per cent (infrequent attenders) among the controls (p equals
0.19 and 0.009 respectively). Reduction in blood pressure 7 mmHg diastolic (not significant) for newly diagnosed
participants and net increase in diastolic blood pressure 4.3 mmHg among infrequent attenders (not statistically
significant, no exact p-value reported)
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Saunders 1991 (Continued)
Notes Dropouts were lower in the intervention groups.
Sclar 1991
Methods Parallel, study duration six months, follow up at six months
Participants 344 previously treated and 109 newly diagnosed hypertensive participants, mean age 57 years, hospital outpatients,
USA
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: Prescription refill pack containing drugs and educational material versus usual supply of drugs
Outcomes PILL COUNT: 34 per cent (newly diagnosed) and 41 per cent (established hypertensives) higher medication pos-
session rates in the intervention groups compared to controls (p less than 0.05 for both groups). Reduction in blood
pressure not reported
Notes No drop-outs reported despite uneven number randomised
Skaer 1993
Methods Factorial, study duration 12 months
Participants 304 participants, previously untreated for mild to moderate hypertension, mean age 56 years, 46 per cent women,
pharmacy, US
Interventions PATIENTMOTIVATION, SUPPORTANDREMINDERS: postal reminder, special unit dose reminder packaging
and both combined versus usual care
Outcomes PRESCRIPTION RECORD: increases in the ’medication possession ratio’ of 8 per cent (postal reminder), 11 per
cent (unit dose packaging) and 23 per cent (both combined ) compared to usual care (p less than 0.05 for all
interventions)
Notes Potential sources of bias not fully reported.
Solomon 1998
Methods Parallel, six months follow-up
Participants 133 participants with treated hypertension, 64 per cent caucasian, 28 per cent black, mean age 67 years, 10 depart-
ments of Veterans Affairs medical centers and one academic medical center, US
Interventions COMPLEX HEALTH AND ORGANIZATIONAL INTERVENTIONS, INTERVENTIONS IN COMBINA-
TION: patient-centred pharmaceutical care model by pharmacy residents versus usual care
Outcomes PILL COUNT AND SELF REPORT: better compliance scores in intervention group (0.23) compared to controls
(0.61, p less than 0.05). Net blood pressure reduction 6.9 mmHg systolic (p less than 0.05) and minus 0.6 mmHg
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Solomon 1998 (Continued)
diastolic (not statistically significant)
Notes Only results from self-report of adherence reported. Likelihood of bias
Webb 1980
Methods Parallel three arm, study duration three months, follow-up at 18 months
Participants 123 participants with treated hypertension, black, 79 per cent women, mean age 55 years, primary care, USA
Interventions PATIENT EDUCATION ANDPATIENTMOTIVATION, SUPPORT ANDREMINDERS: education or coun-
selling versus usual care
Outcomes PILL COUNT: differences in adherence scores minus 0.2 for education and plus 0.2 for counselling (p greater than
0.10). Net reduction in diastolic blood pressure 3.3 mmHg for education and 2.3 mmHg for counselling (p greater
than 0.1, respectively)
Notes Unclear on which outcome and treatment difference the power calculation was based on, unequal numbers due to
drop-outs after randomisation but before start of intervention (no reasons given)
Zarnke 1997
Methods Parallel, study duration eight weeks, follow-up at eight weeks
Participants 31 participants with treated and controlled hypertension, 65 per cent women, mean age 54 years, primary care and
hospital outpatients, USA
Interventions PATIENT MOTIVATION SUPPORT AND REMINDERS: home blood pressure monitoring and self-measure-
ment of blood pressure versus usual care
Outcomes NOTCLEARLYDEFINED, PROBABLY PILL COUNT: 0.3 doses missed per subject per week in the intervention
group compared to 0.4 in the control group (not statistically significant, no exact p-value reported). Net reduction
in mean arterial blood pressure 2.9 mmHg (p equals 0.039)
Notes No power calculation but primary and secondary hypotheses stated
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Binstock 1988 No usual care control group
Casebeer 1995 Publication is a report of a study design only, not a study report. The study itself has to our knowledge not
been published yet
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(Continued)
Eisen 1990 No contemporary control group
Gonzalez-Fern. 1990 Hospital setting
Powers 1982 Unable to interpret results
Strogatz 1983 No adherence outcome
Takala 1979 No adherence outcome
Zismer 1982 No adherence outcome
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Quality assessment of included trials and potential sources of bias
Study Random. appropriate? Outcome ass. blind? Losses to follow up Comment
Sackett 1975 not reported yes 10/144 (6.9 per cent) No power
calculation stated as such,
but important differences
stated a priori
Eshelman 1976 not reported not reported 33/100 (33 per cent) No differential loss to fol-
low up reported.
Haynes 1976 yes yes 5/39 (12.8 per cent) Lacked statis-
tical power. Power calcu-
lation was performed, but
no exact figures reported
Gabriel 1977 not reported not reported none No power calculation re-
ported.
Johnson 1978 not reported yes 4/140 (2.9 per cent) Power calculation not re-
ported, but probabilty of
type II error quantified in
discussion
Hawkins 1979 yes no 519/1148 (45.2 per cent) High losses to follow up
Logan 1979 not reported yes 41/457 (9 per cent) Differential loss to follow
up well reported
Nessman 1980 not reported no not reported Only 10 per cent of eligi-
ble patients took part in
the study, which may in-
dicate self selection
Rehder 1980 not reported not reported 52/100 (52 per cent) High losses to follow up
ans small sample size for a
factorial trial
Webb 1980 not reported not reported not reported Unclear on what outcome
and treatment difference
the power calculation was
based on
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Table 1. Quality assessment of included trials and potential sources of bias (Continued)
Kirscht 1981 not reported not reported 66/417 (15.8 per cent) Results difficult to inter-
pret.
Logan 1983 yes yes 9/194 Randomisation process
seems adequate but is not
entirely clear
Asplund 1984 not reported not reported 30/160 (18.8 per cent) Differential losses to fol-
low up not clearly re-
ported
Baird 1984 not reported not reported 50/289 (17.3 per cent) Detailed reasons for losses
to follow up given
Pierce 1984 yes yes 2/115 (1.7 per cent) Outcomes poorly
reported.
Kerr 1985 not reported not reported 52/116 (44.8 per cent) Large
dropouts in all groups, in-
consistencies between de-
nominators in tables and
dropouts, which vary for
blood pressure and adher-
ence outcomes
Morisky 1985 not reported not reported 110/400 (27.5 per cent) No significant differences
between dropouts and
those who continued to
receive care
Becker 1986 not reported not reported 15/180 (8.3 per cent) Physicians were blinded
to treatment allocation.
They were aware that
compliance study was in
progress but unaware of
the aims of the study
Burrelle 1986 not reported not reported None Small study
Burris 1991 yes yes 9/58 (15.5 per cent) No p-values reported for
adherence outcome
Saunders 1991 no yes 33/224 (14.7 per cent) Dropouts were lower in
the intervention groups
but much higher in the
’newly treated’ group than
among the ’infrequent at-
tenders’
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Table 1. Quality assessment of included trials and potential sources of bias (Continued)
Sclar 1991 not reported not reported not reported No dropouts reported de-
spite uneven number ran-
domised.
McKenney 1992 not reported not reported not reported Nine participants
required a change in med-
ication during the second
phase of the study
Hamilton 1993 not reported not reported 4/34 (11.8 per cent) Small sample size.
Skaer 1993 yes yes not reported Losses to follow up not re-
ported.
Detry 1995 not reported no 18/640 (2.8 per cent) Cross over RCT, patients
were double counted
Boissell 1996 yes no 253/7274 (3.5 per cent) No differential loss to fol-
low up reported. High
number of participants
due to large number
of participating general
practitioners
Friedman 1996 not reported yes 34/267 (12.7 per cent) Treat-
ment provider blinded
until baseline measure-
ment was completed
Park 1996 not reported no 11/64 (17.2 per cent) Small study
Leenen 1997 yes yes 21/198 (10.6 per cent) Compared two differ-
ent drugs. Only reported
within group comparison
Zarnke 1997 yes not reported not reported No power calculation but
primary and secondary
hypotheses were stated
Marquez-Contreras
1998
not reported not reported 15/110 (13.6 per cent) Differential loss to follow
up in both treatment arms
not reported
Mounier-Vehier 1998 not reported not reported 18/103 (17.5 per cent) Treatment allocation ac-
cording to ’enrollment or-
der’ and ’randomisation
list’
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Table 1. Quality assessment of included trials and potential sources of bias (Continued)
Solomon 1998 not reported no not reported Multiple potential sources
of bias
Girvin 1999 not reported yes 2/27 (7.4 per cent) Small study.
Andrejak 2000 yes no 29/162 (17.9 per cent) Differential loss to follow
up well reported.
Blenkinsopp 2000 not reported not reported 40/282 (14.2 per cent) Randomisation at phar-
macy level. Complete data
on blood pressure avail-
able only on 100 patients
Mehos 2000 not reported not reported 5/41 (12.2 per cent) High likelihood of bias.
WH A T ’ S N E W
Last assessed as up-to-date: 25 February 2004.
Date Event Description
13 August 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 4, 1999
Review first published: Issue 2, 2004
Date Event Description
26 February 2004 New citation required and conclusions have changed Substantive amendment
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